GREENWICH, Conn., Oct. 9, 2013 /PRNewswire/ -- Sarissa Capital today issued the following open letter to shareholders of Astex Pharmaceuticals, Inc. (NASDAQ: ASTX):
Dear Fellow Shareholders,
We recently learned that an Astex partnered cancer drug is about to enter Phase III......
More...
